These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26663046)

  • 21. Multiple system atrophy and CAG repeat length: A genetic screening of polyglutamine disease genes in Italian patients.
    Mongelli A; Sarro L; Rizzo E; Nanetti L; Meucci N; Pezzoli G; Goldwurm S; Taroni F; Mariotti C; Gellera C
    Neurosci Lett; 2018 Jun; 678():37-42. PubMed ID: 29715545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphic CAG repeat length in the androgen receptor gene and association with neurodegeneration in a heterozygous female carrier of Kennedy's disease.
    Greenland KJ; Beilin J; Castro J; Varghese PN; Zajac JD
    J Neurol; 2004 Jan; 251(1):35-41. PubMed ID: 14999487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project.
    Akçimen F; Ross JP; Liao C; Spiegelman D; Dion PA; Rouleau GA
    Mov Disord; 2021 Feb; 36(2):514-518. PubMed ID: 33159825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2).
    Ramos EM; Martins S; Alonso I; Emmel VE; Saraiva-Pereira ML; Jardim LB; Coutinho P; Sequeiros J; Silveira I
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):524-531. PubMed ID: 19676102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
    Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene.
    Maguire JA; Gagne AL; Gonzalez-Alegre P; Davidson BL; Shakkottai V; Gadue P; French DL
    Stem Cell Res; 2019 Jan; 34():101361. PubMed ID: 30611021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.
    Daoud H; Belzil V; Martins S; Sabbagh M; Provencher P; Lacomblez L; Meininger V; Camu W; Dupré N; Dion PA; Rouleau GA
    Arch Neurol; 2011 Jun; 68(6):739-42. PubMed ID: 21670397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.
    Tavares de Andrade HM; Cintra VP; de Albuquerque M; Piccinin CC; Bonadia LC; Duarte Couteiro RE; Sabino de Oliveira D; Claudino R; Magno Gonçalves MV; Dourado MET; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Bulle Oliveira AS; Nucci A; Lopes-Cendes I; Marques W; França MC
    Neurobiol Aging; 2018 Sep; 69():292.e15-292.e18. PubMed ID: 29934271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
    Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
    Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias.
    Fournier C; Anquetil V; Camuzat A; Stirati-Buron S; Sazdovitch V; Molina-Porcel L; Turbant S; Rinaldi D; Sánchez-Valle R; Barbier M; Latouche M; ; Stevanin G; Seilhean D; Brice A; Duyckaerts C; Le Ber I
    Acta Neuropathol Commun; 2018 May; 6(1):41. PubMed ID: 29848387
    [No Abstract]   [Full Text] [Related]  

  • 31. RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.
    Nkiliza A; Mutez E; Simonin C; Leprêtre F; Duflot A; Figeac M; Villenet C; Semaille P; Comptdaer T; Genet A; Sablonnière B; Devos D; Defebvre L; Destée A; Chartier-Harlin MC
    Neurobiol Dis; 2016 Dec; 96():312-322. PubMed ID: 27663142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.
    Rosas I; Martínez C; Clarimón J; Lleó A; Illán-Gala I; Dols-Icardo O; Borroni B; Almeida MR; van der Zee J; Van Broeckhoven C; Bruni AC; Anfossi M; Bernardi L; Maletta R; Serpente M; Galimberti D; Scarpini E; Rossi G; Caroppo P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Antonell A; Sánchez-Valle R; De la Casa-Fages B; Grandas F; Diez-Fairen M; Pastor P; Ferrari R; Álvarez V; Menéndez-González M
    Neurobiol Aging; 2020 Mar; 87():139.e1-139.e7. PubMed ID: 31810584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease.
    Taanman JW; Schapira AH
    Neurosci Lett; 2005 Mar; 376(1):56-9. PubMed ID: 15694274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The parkinsonian phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Kuo PC; Chang HC; Weng YH
    Arch Neurol; 2004 Jan; 61(1):35-8. PubMed ID: 14732617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis.
    Lu HP; Gan SR; Chen S; Li HF; Liu ZJ; Ni W; Wang N; Wu ZY
    Neurobiol Aging; 2015 Mar; 36(3):1603.e11-4. PubMed ID: 25457026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of polyglutamine repeats in autosomal dominant Parkinson's disease.
    Yamashita C; Tomiyama H; Funayama M; Inamizu S; Ando M; Li Y; Yoshino H; Araki T; Ichikawa T; Ehara Y; Ishikawa K; Mizusawa H; Hattori N
    Neurobiol Aging; 2014 Jul; 35(7):1779.e17-21. PubMed ID: 24534762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CAA repeat polymorphism in the ZFHX3 gene is associated with risk of coronary heart disease in a Chinese population.
    Sun S; Zhang W; Chen X; Song H
    Tohoku J Exp Med; 2015 Apr; 235(4):261-6. PubMed ID: 25797214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [(CAG)n polymorphism of the ATXN2 gene, a new marker of susceptibility for type 2 diabetes mellitus].
    Flores-Alvarado LJ; Dávalos-Rodríguez NO; García-Cruz D; Madrigal-Ruiz PM; Ruiz-Mejía R; Aguilar-Aldrete ME; Villa-Ruano N; Ramirez-Garcia SA
    Rev Panam Salud Publica; 2016 Nov; 40(5):318-324. PubMed ID: 28076580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longitudinal cohort.
    Xu YD; Zhou XY; Wei SD; Liu FT; Zhao J; Tang YL; Shen B; Ding ZT; Wu JJ; Sun YM; Wang J
    Neurol Sci; 2024 Jul; 45(7):3191-3200. PubMed ID: 38340219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A CAG trinucleotide repeat expansion and familial schizophrenia.
    Ohara1 K; Ikeuchi T; Suzuki Y; Ohtani M; Ohara K; Tsuji S
    Psychiatry Res; 2000 Jul; 94(3):257-62. PubMed ID: 10889290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.